Mithra Pharmaceuticals SA
EBR:MITRA.BR
0.216 (EUR) • At close July 23, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 8.98 | 28.285 | 32.872 | 138.675 | 49.72 | 118.949 | 36.19 | 2.15 | 7.794 | 1.678 | 1.561 | 0.703 |
| Short Term Investments
| 0 | 0 | 0 | 0.014 | 0.046 | 0 | 0 | 43.6 | 89 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 8.98 | 28.285 | 32.872 | 138.689 | 49.766 | 118.949 | 36.19 | 45.75 | 96.794 | 1.678 | 1.561 | 0.703 |
| Net Receivables
| 36.092 | 62.596 | 20.253 | 59.957 | 25.48 | 5.194 | 25.429 | 3.509 | 5.951 | 2.687 | 3.595 | 2.464 |
| Inventory
| 48.289 | 50.312 | 43.852 | 35.38 | 16.276 | 10.945 | 4.141 | 4.17 | 2.797 | 1.763 | 2.413 | 2.412 |
| Other Current Assets
| 0.047 | 4.67 | 2.412 | 4.449 | 3.046 | 8.274 | 8.452 | 4.446 | 3.547 | 2.052 | 0.534 | 0.693 |
| Total Current Assets
| 93.408 | 145.863 | 99.389 | 238.475 | 91.522 | 143.362 | 74.212 | 57.875 | 109.089 | 8.18 | 8.103 | 6.272 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 51.488 | 106.251 | 107.676 | 99.493 | 94.037 | 84.396 | 59.519 | 16.961 | 3.573 | 2.407 | 1.457 | 1.07 |
| Goodwill
| 5.233 | 5.233 | 5.233 | 5.233 | 5.233 | 5.233 | 5.233 | 5.233 | 8.016 | 3.814 | 0 | 0 |
| Intangible Assets
| 108.713 | 140.138 | 110.187 | 94.238 | 92.723 | 78.802 | 78.81 | 79.13 | 78.234 | 2.181 | 1.725 | 1.887 |
| Goodwill and Intangible Assets
| 113.946 | 145.371 | 115.42 | 99.471 | 97.956 | 84.035 | 84.043 | 84.363 | 86.25 | 2.181 | 1.725 | 1.887 |
| Long Term Investments
| 16.194 | 24.323 | 31.987 | 32.695 | 80.067 | 14.583 | 0.227 | 0.165 | 0.198 | 2.119 | 0.214 | 0 |
| Tax Assets
| 1.289 | 16.354 | 63.456 | 50.905 | 34.431 | 27.045 | 22.718 | 12.193 | 5.345 | 0.563 | 0.157 | 0.359 |
| Other Non-Current Assets
| 10.221 | 4.252 | 3.99 | 0.946 | -0.37 | -41.628 | -22.945 | -12.193 | -5.345 | -0.563 | 0.248 | 0.06 |
| Total Non-Current Assets
| 193.138 | 296.551 | 322.529 | 283.51 | 306.121 | 168.431 | 143.562 | 101.489 | 90.021 | 6.707 | 3.801 | 3.376 |
| Total Assets
| 286.546 | 442.414 | 421.918 | 521.985 | 397.643 | 359.728 | 244.712 | 172.696 | 205.587 | 15.697 | 11.904 | 9.648 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 59.072 | 31.716 | 16.915 | 23.325 | 19.449 | 13.071 | 16.141 | 9.312 | 4.613 | 3.544 | 2.581 | 1.418 |
| Short Term Debt
| 26.703 | 52.411 | 53.128 | 18.792 | 13.272 | 20.253 | 15.744 | 6.955 | 17.854 | 23.214 | 3.446 | 3.597 |
| Tax Payables
| 0 | 0 | 0 | 0.036 | 0.093 | 0.334 | -0.004 | 0.073 | 0.043 | 0.31 | 1.161 | 0.376 |
| Deferred Revenue
| 2.507 | 1.417 | 1.617 | 1.259 | 0.791 | -20.253 | -15.744 | -6.955 | 0.663 | -23.214 | 0 | 1.301 |
| Other Current Liabilities
| -43.373 | 13.171 | 7.218 | 4.01 | -5.254 | 9.633 | 4.195 | 2.053 | 6.754 | -22.089 | -1.592 | -1.795 |
| Total Current Liabilities
| 103.981 | 130.431 | 95.793 | 70.747 | 47.8 | 36.109 | 52.217 | 27.705 | 34.54 | 8.523 | 8.177 | 6.315 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 147.53 | 137.762 | 125.237 | 124.508 | 19.056 | 118.236 | 69.189 | 48.242 | 37.696 | 1.65 | 1.239 | 1.327 |
| Deferred Revenue Non-Current
| 17.947 | 8.127 | 12.769 | 18.901 | 17.142 | 4.016 | 0.495 | 8.255 | 8.513 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 1.081 | 4.42 | 6.09 | 4.364 | 4.146 | 2.202 | 2.099 | 3.469 | 5.692 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 119.264 | 127.987 | 148.189 | 145.728 | 146.201 | -6.218 | -2.594 | -11.724 | -14.205 | -1.65 | -1.239 | 0.001 |
| Total Non-Current Liabilities
| 285.822 | 278.296 | 292.285 | 293.501 | 186.545 | 118.236 | 69.189 | 48.242 | 37.696 | 1.65 | 1.239 | 1.328 |
| Total Liabilities
| 389.803 | 408.727 | 388.078 | 364.248 | 234.345 | 208.835 | 157.83 | 79.681 | 78.193 | 10.173 | 9.416 | 7.643 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 50.594 | 41.228 | 32.25 | 31.271 | 28.649 | 26.925 | 25.036 | 22.613 | 22.613 | 3.107 | 5.041 | 2.48 |
| Retained Earnings
| -589.294 | -396.254 | -336.634 | -219.759 | -127.673 | -101.109 | -88.744 | -53.733 | -18.645 | -8.154 | -2.553 | -0.475 |
| Accumulated Other Comprehensive Income/Loss
| 10.586 | -19.934 | -2.545 | 13.69 | 3.424 | 1.254 | 2.311 | 1.305 | 0.597 | 0 | -0.7 | -0.545 |
| Other Total Stockholders Equity
| 424.859 | 408.647 | 340.769 | 332.535 | 258.898 | 223.823 | 148.279 | 122.83 | 122.829 | 10.571 | 0.7 | 0.545 |
| Total Shareholders Equity
| -103.255 | 33.687 | 33.84 | 157.737 | 163.298 | 150.893 | 86.882 | 93.015 | 127.394 | 5.524 | 2.488 | 2.005 |
| Total Equity
| -103.255 | 33.687 | 33.84 | 157.737 | 163.298 | 150.893 | 86.882 | 93.015 | 127.394 | 5.524 | 2.488 | 2.005 |
| Total Liabilities & Shareholders Equity
| 286.546 | 442.414 | 421.918 | 521.985 | 397.643 | 359.728 | 244.712 | 172.696 | 205.587 | 61.019 | 11.904 | 9.648 |